FDA Import Refusal 8NP-0055905-8/11/1 — Janssen Biologics B.V.
The FDA refused shipment 8NP-0055905-8/11/1 from Janssen Biologics B.V. (Netherlands) on April 19, 2021. The refused product falls under Drugs and Biologics — USTEKINUMAB (ANTI-PSORIATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- April 19, 2021
- Country
- Netherlands
- Product Category
- Drugs and Biologics
- Product Code
- 62NAA09 USTEKINUMAB (ANTI-PSORIATIC)
- Charges
- 75